SCP VITALIFE MANAGEMENT COMPANY, LLC

Thesis

SCP Vitalife Management Company, LLC, operating as SCP Vitalife Partners, is a venture capital firm founded in 2002. The firm specializes in the life sciences sector, with a particular emphasis on therapeutic medical devices. Their investment thesis targets early to mid-stage companies possessing exceptional technology, proprietary advantages, and breakthrough products that address significant unmet medical needs, with a strong preference for innovations protected by robust intellectual property. While SCP Vitalife invests in both the U.S. and Israel, it strategically allocates over half of its capital to Israeli companies, recognizing the country as a leading hub for life science technology, especially in medical devices. The firm often takes a lead or co-lead role in seed and Series A rounds, providing hands-on support and leveraging strategic partnerships to foster growth. With approximately $230 million under management across two funds, SCP Vitalife Partners II, L.P. has total assets of $112.7 million. The firm targets initial investments of $3-$7 million, with a typical total investment of $7-$15 million over the investment lifecycle.